|
|
||||||||
Technical Innovation |
1 Department of Radiology, Center for Advanced Medical Technology, Nippon
Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8602, Japan.
2 Department of Surgery 1, Nippon Medical School, Tokyo 113-8602, Japan.
3 Department of Advanced Emergency Critical Care Medicine, Nippon Medical
School, Tokyo 113-8602, Japan.
Received April 25, 2003;
accepted after revision August 19, 2003.
Address correspondence to H. Tajima
(h-tajima{at}nms.ac.jp).
Introduction
|
|
|---|
|
|
|---|
Patients
Between May 2000 and December 2000, three consecutive patients with severe
neck pain and swelling due to internal jugular vein thrombosis were
prospectively selected for interventional treatment. One woman and two men,
ages 43, 66, and 71 years, were selected. The patients had a postsurgical
condition that began after clipping a cerebral aneurysm, coronary artery
bypass graft for myocardial infarction, or hemicolectomy for colon cancer. Two
patients developed thrombosis as a result of trauma to the internal jugular
vein from catheterization, and one developed a spontaneous case. The affected
side was the right in one patient and the left in two patients. Before
treatment, the extent of thrombus formation was evaluated using
contrast-enhanced CT. Follow-up CT was performed 37 days after the
procedures. Sonography and MR venography were not used because they are not
available to emergency patients at our hospital.
Percutaneous Interventional Procedures
A temporary filter (Antheor, Boston Scientific, Watertown, MA) was inserted
into the superior vena cava via the left femoral vein for protection against
large emboli. A 6-French short sheath was inserted in the right femoral vein,
and a 5-French catheter for cerebral angiography (Headhunter catheter,
Medikit, Tokyo, Japan) was advanced into the thrombosed internal jugular vein
using a guidewire (Radifocus, Terumo, Tokyo, Japan).
Through the catheter, a 260-cm extrastiff guidewire (Amplatz, Cook, Bloomington, IN) was guided into the central thrombosed internal jugular vein. The Headhunter catheter was then withdrawn, leaving the guidewire in the central internal jugular vein. The short 6-French sheath was exchanged with a 10-French sheath, and a mechanical thrombectomy system (Oasis [10-French], Medi-Tech/Boston Scientific, Watertown, MA) was used. The thrombectomy system was advanced repeatedly for mechanical thrombectomy.
An 8-French long sheath with a hemostatic valve was advanced into the internal jugular vein. Then a modified pigtail catheter was advanced into the thrombus. Emboli were fragmented by the mechanical action of the rotating pigtail catheter. The catheter was rotated manually and advanced or withdrawn over the guidewire.
An 8-French aspiration catheter (Judkins Right 3.5 Percutaneous Transluminal Coronary Angioplasty Guider, Boston Scientific Scimed, Maple Grove, MN) was advanced into the thrombus. A 10-mL syringe with a connector was used to apply suction while the catheter was moved slowly back and forth across an area of several centimeters in the thrombus. During advancement with this technique, it is important to be aware of any resistance because resistance may indicate subintimal passage of the catheter. When blood readily entered the syringe, the thrombus was assumed to have cleared the catheter. The syringe was removed and its contents were expressed over a gauze-draped basin. Multiple aspirations can be performed if necessary [1].
Local infusion of urokinase (2436 x 104 U) was administered over 2436 min. After complete clot removal, final dilatation of the stenotic orifice of the internal jugular vein was performed with a standard balloon (Ultra-Thin Diamond [10-mm-diameter], Medi-Tech/Boston Scientific). We used these techniques as needed for each patient.
During the aspiration thrombectomy, all patients received heparin sodium treatment to reach an activated partial thromboplastin time ratio of 2. Additional systemic urokinase infusion was administered at an ICU, depending on the patient's condition.
|
|
|---|
All patients survived, and their clinical status improved. In two patients, angiography performed soon after treatment showed complete resolution of venous perfusion, and the procedure was finished the same day. In the third patient (Fig. 1A, 1B, 1C, 1D, 1E, 1F, 1G), a small thrombus remained, so we recommended systemic thrombolysis (urokinase, 360,000 U/day for 6 days) and tried a second intervention 6 days later; the second intervention was successful. A prophylactic temporary superior vena cava filter was used in all patients, and no symptomatic pulmonary thromboembolism was encountered. Follow-up contrast-enhanced CT in each patient revealed no residual thrombosis of the internal jugular vein. No patient experienced any significant complications during or after the procedures, and no recurrence of symptoms had occurred in any of the patients.
|
|
|
|
|
|
|
|
|
|---|
Prophylactic Temporary Filter
Clinical and experimental researchers have reported observing numerous
thrombi in the inferior vena cava filter after placing it to treat deep vein
thrombosis of the lower extremities. Therefore, in this study, to avoid the
risk of any embolic event, we deemed it essential to use a temporary superior
vena caval filter to avoid the possibility of this complication.
Mechanical Embolectomy
Although effective, conventional thrombolysis is associated with a high
risk of bleeding; mechanical thrombectomy is therefore a novel approach to the
treatment of internal jugular vein thrombosis. Several small studies have
shown that mechanical thrombectomy devices can be used to remove venous
thrombi quickly and effectively in the treatment of deep venous thrombosis and
pulmonary thromboembolism. We used a 10-French Oasis device, which allowed
efficient thrombus removal.
The technique of fragmentation with a special pigtail catheter system has been described [6, 7]. The rotational movement of the pigtail portion of the catheter acts directly on the clots in the internal jugular vein, causing fragmentation and distal migration of the smaller fragments. In this study, we undertook this additional procedure in one patient for the management of residual clots.
Thromboaspiration
Percutaneous aspiration thrombectomy evolved from a simple technique
previously used in many fields
[1]. The thin wall of the
aspiration catheter ensures the maximum internal luminal diameter for
aspiration of the thrombus [1].
Aspiration of a pulmonary clot using a large-lumen percutaneous transluminal
coronary angioplasty guiding catheter has been reported
[8]. This technique is less
invasive for the vessels and is convenient to perform with the use of a small
8-French introducer sheath and a conventional percutaneous transluminal
coronary angioplasty guiding catheter in a standard angiography laboratory. It
is also inexpensive.
Thrombectomy and thromboaspiration have a possible synergistic effect with concurrent thrombolytic therapy because a large surface area of the resulting clot fragments is exposed to the thrombolytic agent, thus improving the results of lytic activity and allowing a reduction of dose and infusion time. In one patient, we used low-dose urokinase, which is less dangerous, with success. In the other two patients, we did not have to use thrombolytic therapy because of the excellent results of thrombectomy and thromboaspiration.
After complete clot removal, performing a final dilatation of the stenotic orifice of the internal jugular vein is necessary. The main purpose of this procedure is to maintain an efficient central channel in the orifice of the vessel. Because the dilatation was effective in all patients in this study, we did not have to use metal stents. Because creating septic emboli with the percutaneous interventional therapy is a risk, prophylactic antibiotic therapy is needed.
The major limitation of this study is the relatively small number of patients included. Future studies are required to establish the role of interventional treatment in the management of acute and chronic internal jugular vein thrombosis, to determine whether thrombectomy and percutaneous transluminal balloon angioplasty may play a role in the prevention of pulmonary thromboembolism in selected patients, and to identify the optimal adjunct pharmacologic, mechanical, and dilatational therapies.
In conclusion, the percutaneous interventional procedures reported here achieved a rapid and safe improvement in the venous circulation of patients with acute internal jugular vein thrombosis.
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |